Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Srivastava Y et al
FOXO4-DRI Based on 1 publication(s) in Google Scholar FOXO4-DRI is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53
The lack of robust BPC-157 human trialsspecifically Phase II and Phase III studiesmeans that definitive conclusions about its efficacy, optimal dosing, and long-term safety in humans cannot be made
GHK-Cu (Copper Peptide) Third-Party Tested COA Available GHK-Cu is a copper-binding tripeptide used in laboratory research for peptide signaling and copper transport studies
A clinical approach to skin health, not a cosmetic one
B.1994Glycine and taurine conjugation of bile acids by a single enzyme
US$ 26.27
US$ 29.35
US$ 23.28
US$ 23.67
